Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.00
12.90
(1.40%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences - Quaterly Results
>>
Zydus Lifesciences reports marginal rise in Q3 consolidated net profit
>>
Zydus Lifesciences secures USFDA Orphan Drug Designation for Desidustat
>>
Zydus Lifesciences rises on getting USFDA’s tentative nod for Dapagliflozin tablets
>>
Zydus Lifesciences gets USFDA’s tentative nod for Dapagliflozin tablets
>>
Zydus Lifesciences informs about investor conference
>>
USFDA conducts inspection at Zydus group’s Unit-2 manufacturing plant at Ankleshwar
>>
Zydus Lifesciences gains on launching Nivolumab biosimilar ‘Tishtha’ in India
>>
Zydus Lifesciences launches Nivolumab biosimilar ‘Tishtha’ in India
>>
Zydus Lifesciences informs about press release
<<
<
3
4
5
...168
>
>>